Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Lovestone

Showing results (211-220 of 333) with videos related to

Pageof 34
Sort By:
Journal of Alzheimer'S Disease : JAD|September 25, 2015
No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's DiseaseJustin Tao Wen Chiam, Katie Lunnon, Nicola Voyle, et al.
Frontiers in Aging Neuroscience|December 16, 2022
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networksYuting Zhang, Upamanyu Ghose, Noel J Buckley, et al.
Frontiers in Neuroscience|August 10, 2018
Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived NeuronsJacqueline P Robbins, Leo Perfect, Elena M Ribe, et al.
Journal of Alzheimer'S Disease : JAD|April 1, 2016
Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented ElderlySarah Westwood, Emanuela Leoni, Abdul Hye, et al.
Human Molecular Genetics|August 30, 2007
Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's diseaseMarian L Hamshere, Peter A Holmans, Dimitrios Avramopoulos, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 27, 2022
Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease riskRobert F Hillary, Danni A Gadd, Daniel L McCartney, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 16, 2014
Circulating Proteomic Signatures of Chronological AgeCristina Menni, Steven J Kiddle, Massimo Mangino, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Pageof 34

Showing results (211-220 of 333) with videos related to

Sort By:
Pageof 34
Journal of Alzheimer'S Disease : JAD|September 25, 2015
No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's DiseaseJustin Tao Wen Chiam, Katie Lunnon, Nicola Voyle, et al.
Frontiers in Aging Neuroscience|December 16, 2022
Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networksYuting Zhang, Upamanyu Ghose, Noel J Buckley, et al.
Frontiers in Neuroscience|August 10, 2018
Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived NeuronsJacqueline P Robbins, Leo Perfect, Elena M Ribe, et al.
Journal of Alzheimer'S Disease : JAD|April 1, 2016
Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented ElderlySarah Westwood, Emanuela Leoni, Abdul Hye, et al.
Human Molecular Genetics|August 30, 2007
Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's diseaseMarian L Hamshere, Peter A Holmans, Dimitrios Avramopoulos, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 27, 2022
Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease riskRobert F Hillary, Danni A Gadd, Daniel L McCartney, et al.
Alzheimer'S Research & Therapy|October 27, 2017
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 16, 2014
Circulating Proteomic Signatures of Chronological AgeCristina Menni, Steven J Kiddle, Massimo Mangino, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Alzheimer'S Research & Therapy|August 1, 2018
Correction to: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's diseaseCraig W Ritchie, Tom C Russ, Sube Banerjee, et al.
Pageof 34